esophageal squamous cell carcinoma
Tevimbra Approved for Some Patients With Unresectable or Metastatic ESCC
The FDA has approved Tevimbra, in combination with platinum-containing chemotherapy, for the first-line treatment ...
MARCH 4, 2025
Tevimbra Approved for Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Prior Chemo
The FDA approved Tevimbra as monotherapy for adult patients with unresectable or metastatic esophageal squamous ...
MARCH 20, 2024
Keytruda Monotherapy Granted Esophageal Cancer Indication
The FDA approved Keytruda monotherapy for patients with recurrent locally advanced or metastatic PD-L1 ...
AUGUST 1, 2019
Load more